Abstract:Abstract BACKGROUND AND AIMS Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a necrotizing vasculitis characterized by inflammation of small blood vessels, being the kidney one of the most frequently affected organs. AAV has a high morbidity and mortality, developing rapidly progressive renal failure that could lead to end-stage renal disease (ESRD). The pathogenesis is complex and multifactorial; macrophages have turned out to be a key element in inflammation and also in fibrosis. As already described in previous publications, PR3-AAV and MPO-AAV show clinical-demographic differences and different renal phenotypes on kidney biopsy. Histopathological subgrouping into four classes (focal, crescentic, mixed and sclerotic, as defined by Berden et al.) was proposed to predict long-term renal survival rates, poorest in the sclerotic class. This classification, validated by our group and multiple others, is still under review. The aim of this study is to demonstrate whether interstitial fibrosis in AAV is at least as important as glomerular sclerosis in renal prognosis, being a differentiating element between MPO and PR3 vasculitis. METHOD We performed a retrospective single-center study of 95 AAV-patients (78 MPO-AAV and 17 PR3-AAV) diagnosed by renal biopsy from 1991 to 2021 and at least 1-year follow-up. Clinical and laboratory variables, presence and type of ANCA, immunosuppressant therapy and renal/patient survival were evaluated. Sixty-two kidney biopsy samples have been analyzed: histomorphometric quantification has been carried out using MetaMorph® software on trichrome-stained slides in order to measure the degree of fibrosis. Continuous variables were described using measures of central tendency and dispersion (mean and standard deviation), and categorical variables using frequency tables and percentages. Student's t-tests or Mann–Whitney U tests, as appropriate, were performed to evaluate differences in mean values, and chi-squared tests were used to evaluate differences in qualitative variables. Statistical significance was defined as P-values <.05. All P-values were two-sided. RESULTS PR3-AAV population was predominantly male (70%) with a mean age at diagnosis of 62 years and a mean follow-up of 54 months, while MPO-AAV population was mainly female (65.8%), mean age 66 years and follow-up 65 months. There were no statistically significant differences in renal function between MPO and PR3-AAV at diagnosis. However, our data showed that MPO-AAV had worse renal function than PR3-AAV at the end of follow-up (P = .01). Furthermore, it should be highlighted that renal function improved throughout the follow-up (P < .01 and P = .05 in MPO and PR3-AAV, respectively). From a histological point of view: MPO-AAV manifests more interstitial fibrosis at diagnosis than PR3-AAV (P = .01). However, there were no statistically differences in the amount of glomerular sclerosis. It is noteworthy that PR3-AAV showed more crescentic proliferation at diagnosis (P = .03) but less fibrotic crescents than MPO-AAV (not reaching statistical significance). CONCLUSION The method we used allows a quantitative assessment of renal fibrosis. Our data confirm that renal prognosis is better in PR3-AAV than in MPO-AAV, which could be explained by a greater interstitial fibrosis, as well as more fibrotic crescentic in MPO-AAV at diagnosis.

Antineutrophil Cytoplasmic Antibody–Associated Lung Fibrosis

Clinical analysis of antineutrophil cytoplasmic autoantibody-associated vasculitis manifested as pulmonary fibrosis.

Pathological Classification and Prognosis of Renal Damage Caused by Antineutrophil Cytoplasmic Antibody Associated Vasculitis

MO253: Interstitial Fibrosis in Anca-Associated Vasculitis: MPO Versus PR3-A Single-Center Experience

ANCA-associated vasculitis and lung cancer: an immunological perspective

Progression to ANCA-associated vasculitis in patients with idiopathic interstitial pneumonia and positive ANCA

Predictors of Treatment Resistance and Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Study of 439 Cases in a Single Chinese Center

History of antineutrophil cytoplasmic autoantibodies

Clinical analysis of 10 cases of ANCA associated vasculitis with pulmonary involvement as primary manifestation

Pulmonary manifestations associated with positive anti neutrophil cytoplasmic antibodies: The tip of the iceberg

Identification of neutrophil β2-integrin LFA-1 as a potential mechanistic biomarker in ANCA-associated vasculitis via microarray and validation analyses

Clinical Manifestations and Pulmonary Radiological Findings of Primary Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Pulmonary Involvement of ANCA-associated Vasculitis in Adult Chinese Patients.

Association of antineutrophil cytoplasmic antibody (ANCA) specificity with the demographic and clinical characteristics of patients with ANCA-associated vasculitides.

The Prevalence and Management of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China

ANCA negative pulmonary vasculitis: a challenging diagnosis

Pneumocystis jirovecii Pneumonia Prophylaxis in Patients with ANCA Vasculitis on Rituximab Maintenance Therapy

Clinical Feature Analysis of 190 Patients with Anti-Neutrophil Cytoplasmic Antibodies Associated Vasculitis

Epitope Analysis of Anti-Myeloperoxidase Antibodies in Patients with ANCA-associated Vasculitis

E078 Long term outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis: a single centre study

Development of a novel predictive model for interstitial lung disease in ANCA-associated vasculitis prognostications within the Chinese population